WtEGFR also plays a critical oncogenic role in GBM, contributing to tumor cell invasion [29], and heterogeneous co-expression of wild type and mutant EGFR contributes to drug resistance in GBM [37]. This evidence concerns the gene EGFR and glioblastoma.